Targeting EMT in cancer: opportunities for pharmacological intervention
Davis, Felicity, Stewart, Teneale, Thompson, Erik W, & Monteith, Gregory (2014) Targeting EMT in cancer: opportunities for pharmacological intervention. Trends in Pharmacological Sciences, 35(9), pp. 479-488.
•EMT is important for embryonic development, wound healing, and placentation. •Some cancers appear to exploit this process for increased metastatic potential. •Therefore, this pathway is of great therapeutic interest in the treatment of cancer.
The spread of cancer cells to distant organs represents a major clinical challenge in the treatment of cancer. Epithelial–mesenchymal transition (EMT) has emerged as a key regulator of metastasis in some cancers by conferring an invasive phenotype. As well as facilitating metastasis, EMT is thought to generate cancer stem cells and contribute to therapy resistance. Therefore, the EMT pathway is of great therapeutic interest in the treatment of cancer and could be targeted either to prevent tumor dissemination in patients at high risk of developing metastatic lesions or to eradicate existing metastatic cancer cells in patients with more advanced disease. In this review, we discuss approaches for the design of EMT-based therapies in cancer, summarize evidence for some of the proposed EMT targets, and review the potential advantages and pitfalls of each approach
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Epithelial-mesenchymal transition (EMT), cancer, metastasis, invasion, therapy resistance, cancer stem cells, mesenchymal-epithelial transition (MET)|
|Copyright Owner:||© 2014 Elsevier Ltd|
|Deposited On:||02 Nov 2015 01:33|
|Last Modified:||02 Nov 2015 01:33|
Repository Staff Only: item control page